Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
FrieslandCampina
With
Sprim Advanced Life Sciences
Age
0–2
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subjects with electronic/physical medical records that contain sufficient data to answer the primary question (i.e. data on growth and dermatological symptoms (based on the SCORAD score) at diagnosis and follow up data of at least 2 months or successful completion of therapy according to the PI (whichever comes first).
Subjects ≤24 months of age at the moment of suspected or diagnosed CMPA with records available between January 2016 to September 2020.
Subjects prescribed with Frisolac Gold Intensive HA and/or Frisolac Gold PEP AC for the dietary management of their CMPA symptoms.
You may not be if
Subjects using other formula products/breast milk alongside Frisolac Gold Intensive HA or Frisolac Gold PEP AC during the time of their participation in the study.
Premature children, or children with low birth-weight (weight at birth \<2.5 kg).
Subjects diagnosed with a metabolic condition that impacts development and growth.
Subjects diagnosed with a congenital condition and/or with prior or current disease that in the opinion of the PI could potentially interfere with their participation in the study.
